The XAPRYLLA brand, founded in 2006 (France), from 2757 sister brands and 17477 competing brands. The XAPRYLLA brand is owned by SANOFI, a company listed in Paris. The International Securities Identification Number (ISIN) of SANOFI is FR0000120578. The sector of XAPRYLLA is Drug Manufacturers.
Investment simulator :
Portfolio valuation
SANOFI
(XAPRYLLA)
over 5 years*
EUR 113.28